Galbato Chan purchased $31K of EML

Eastern Company reported Q2 2026 results on an earnings call, citing an 11.9% YoY sales decline from lower shipments in legacy truck and packaging. Management said gross margin and EBITDA improved, backlog rose 45% YoY to $126M, and it expects most backlog conversion in H2 2026. It discussed aerospace acquisitions (Sungear, Crown Precision), tariffs ($1.9M), and ERP transition at Velvac.

Eastern (NASDAQ:EML) reported sequential Q2 improvement in sales, gross margin and adjusted EBITDA, while year-over-year results were lower. Backlog rose to $126.2M as of July 4, up $39M (45%); management expects most to convert to revenue in 2026. Q2 gross margin fell to 20.6% from 23.3%. Eastern completed Crown Precision and Sungear acquisitions on June 1 for $7.85M.

The Eastern Company (NASDAQ:EML) reported second-quarter 2026 results for the period ended July 4, 2026. Net sales fell 12% to $61.8 million and gross margin was 20.6%. Backlog rose 45% to $126.2 million. The company said results reflect its June 1 acquisitions of Sungear and Crown Precision, and it repurchased 19,529 shares.

EASTERN CO (EML) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 FOR IMMEDIATE RELEASE THE EASTERN COMPANY REPORTS SECOND QUARTER 2026 RESULTS · Acquired Two Precision Manufacturers, Extending Eastern into the Aerospace and Defense Markets · Backlog Increased 45% Year-Over-Year to $126.2 Million, Driven by Acquired Aerospace Order

The Eastern Company (NASDAQ:EML) said it will acquire Sungear LLC and Crown Precision for $7.85 million (cash-free, debt-free) to form its fourth operating platform focused on aerospace and defense precision manufacturing. The deal is funded via borrowings under its revolving credit facility and the targets generated about $22.8 million in trailing-twelve-month revenue ended April 1, 2026.

Brille Brian J (See Remarks) sold 400,000 shares of Caris Life Sciences, Inc. (CAI) at $30.33 ($12.13M total) on 2026-09-17.